Navigation Links
Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Date:6/6/2008

ls of plasma and urinary isoprostanes, CRP, myeloperoxidase, paraoxonase and other markers of inflammation or oxidative stress.

Trial 203 was a Phase 2, placebo-controlled study evaluating 40mg of SYI-2074 administered three times daily for two days in diabetic patients undergoing angioplasty. The primary endpoint of the study was reduction of the amount of heart muscle enzyme (CK-MB) released from the heart as a consequence of the procedure. Results showed that there was no significant reduction in CK-MB, which indicates that the normal damage to heart muscle following an angioplasty occurred during the procedure regardless of the administration of SYI-2074.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit inflammation related to oxidative stress. It currently plans a program in psoriasis with its lead compound. The Company is developing a clinical diagnostic test, based on cardiovascular risk assessment, using Haptoglobin characterization, to identify patients at high risk for cardiovascular complications of diabetes. It is also developing a kit to measure CML, another potential cardiovascular risk marker.

Synvista Therapeutics also is developing alagebrium, a proposed breaker of AGEs for the treatment of diastolic heart failure. This disease represents a rapidly growing market of unmet medical need, particularly common among diabetic patients. Alagebrium has demonstrated relevant clinical activity in two Phase 2 clinical trials in heart failure, as well as in animal models of heart failu
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
2. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
3. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
4. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
5. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
6. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
11. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Intelomed is pleased to announce that ... as the Vice President of Clinical Affairs. With over ... device industry, Kay,s experience in taking medical technology and ... to global expansion, is a valuable addition to the ... on our team, and I am confident her focused ...
(Date:8/26/2014)... Research and Markets has announced ... Report 2014 " report to their offering. ... is a professional and in-depth study on the current ... The report provides a basic overview of the industry ... glucose meter market analysis is provided for both the ...
(Date:8/26/2014)... DUBLIN , Aug. 26, 2014 ... "Global Intranasal Drug Delivery Market 2014-2018" report ... is a medical device used for the administration of ... nose and paranasal sinus such as allergic and non-allergic ... an ideal administrative route for needle-free vaccination and systematic ...
Breaking Medicine Technology:Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 2Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis 3
(Date:8/27/2014)... 2014 Aspirus Wausau Hospital today announced ... with Buzz™ Digital O.R. at Aspirus Wausau Hospital, in ... new operating rooms will be Buzz, a centralized surgical ... system supports planning, navigation, imaging and communications connectivity. ... intuitive software and hardware all controlled from the full ...
(Date:8/27/2014)... 26, 2014 (HealthDay News) -- Health care workers in ... to keep them safe from being infected with blood-borne ... shows. While the study was conducted before the ... its findings are confirmed in statistics released Monday by ... agency reported that an "unprecedented" number of health care ...
(Date:8/27/2014)... patients are 70 per cent more likely to continue ... they have a prescription in hand when discharged ... the Institute for Clinical Evaluative Sciences (ICES). , Using ... Ontarians were taking their medications one week, one year ... reveal the importance of simple interventions, such as giving ...
(Date:8/27/2014)... Hills, CA (PRWEB) August 27, 2014 Bedros ... camp franchise in the world, the leading fitness boot ... Spike TV’s Gym Rescue reality series. One thing he knows ... brand as a subject matter expert in the fitness business. ... to YouTube, he lays out a step-by-step instructional guide on ...
(Date:8/27/2014)... Phoenix, AZ (PRWEB) August 27, 2014 ... that serves the greater Phoenix metropolitan area and all ... client more than $160,000 on a $2 million settlement. ... tangible savings to those who have been injured through ... can be complex and time-consuming, however Hastings and Hastings ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:A prescription for better stroke care 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $166,700 On A Settlement Of $2,000,000 3
... has been released by Australian obesity experts that show gastric ... conference on obesity in Sydney there were three studies which ... in mortality rates in obese people who had the surgery. ... upper part of the stomach for the procedure to restrict ...
... a 4- to 5-point IQ advantage over women by adulthood. ... to 18-year-//olds on the Scholastic Assessment Test (SAT). ... because girls mature faster than boys. This is the reason ... ,145 items from the SAT were examined by a study ...
... of the opinion that eating nuts about twice a week might ... that was presented at the World Congress of Cardiology stated that ... would be around a small plate full might reduce the risk ... survey confirmed that eating a small quantity of the same kinds ...
... hang heavy with heart problems, going back at least two ... she hit age 50,// Catherine got nervous. ,A ... and perhaps those of others in her family tree. She ... causes her heart muscle to grow too thick. The extra ...
... Industry in China has placed on record the successful initial ... vaccine is said to operate in low doses, nearly one-third ... undertaken till date. The smaller doses are proven to be ... observed that just two 10-microgram doses of the Sinovac vaccine, ...
... Scottish Executive have announced their plans to offer dental students ... them in the NHS.// ,It has been explained ... given ?4,000 a year in return for a commitment of ... ,Lewis Macdonald, the deputy health minister, had announced the launch ...
Cached Medicine News:Health News:Greater g factor in men responsible for sex differences in general mental ability 2Health News:Greater g factor in men responsible for sex differences in general mental ability 3Health News:Fight Back Against Inherited Sudden-Death Heart Condition 2Health News:Fight Back Against Inherited Sudden-Death Heart Condition 3Health News:Fight Back Against Inherited Sudden-Death Heart Condition 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: